326 related articles for article (PubMed ID: 15739097)
1. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
Wisłowska M; Jabłońska B
Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
[TBL] [Abstract][Full Text] [Related]
2. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
3. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
Verma P; Dalal K
J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
[TBL] [Abstract][Full Text] [Related]
4. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
5. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
6. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
[TBL] [Abstract][Full Text] [Related]
7. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
[TBL] [Abstract][Full Text] [Related]
8. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis].
Li H; Wang D; Wu ZQ; Zhong JM; Yuan YJ
Zhongguo Gu Shang; 2012 May; 25(5):380-3. PubMed ID: 22870681
[TBL] [Abstract][Full Text] [Related]
10. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
11. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis.
Andersson ML; Thorstensson CA; Roos EM; Petersson IF; Heinegård D; Saxne T
BMC Musculoskelet Disord; 2006 Dec; 7():98. PubMed ID: 17156423
[TBL] [Abstract][Full Text] [Related]
13. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.
Addison S; Coleman RE; Feng S; McDaniel G; Kraus VB
Arthritis Rheum; 2009 Nov; 60(11):3366-73. PubMed ID: 19877068
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis.
Vilím V; Olejárová M; Machácek S; Gatterová J; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2002 Sep; 10(9):707-13. PubMed ID: 12202123
[TBL] [Abstract][Full Text] [Related]
15. Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee.
Sharif M; Granell R; Johansen J; Clarke S; Elson C; Kirwan JR
Rheumatology (Oxford); 2006 May; 45(5):522-6. PubMed ID: 16319098
[TBL] [Abstract][Full Text] [Related]
16. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
Erhart-Hledik JC; Favre J; Asay JL; Smith RL; Giori NJ; Mündermann A; Andriacchi TP
Osteoarthritis Cartilage; 2012 Nov; 20(11):1309-15. PubMed ID: 22868052
[TBL] [Abstract][Full Text] [Related]
17. The heritable determinants of cartilage oligomeric matrix protein.
Williams FM; Andrew T; Saxne T; Heinegard D; Spector TD; MacGregor AJ
Arthritis Rheum; 2006 Jul; 54(7):2147-51. PubMed ID: 16802351
[TBL] [Abstract][Full Text] [Related]
18. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
[TBL] [Abstract][Full Text] [Related]
19. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project.
Jordan JM; Luta G; Stabler T; Renner JB; Dragomir AD; Vilim V; Hochberg MC; Helmick CG; Kraus VB
Arthritis Rheum; 2003 Mar; 48(3):675-81. PubMed ID: 12632420
[TBL] [Abstract][Full Text] [Related]
20. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training.
Petersen SG; Saxne T; Heinegard D; Hansen M; Holm L; Koskinen S; Stordal C; Christensen H; Aagaard P; Kjaer M
Osteoarthritis Cartilage; 2010 Jan; 18(1):34-40. PubMed ID: 19679221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
